They Said It Didn't Make 'Cents': -MS-, the Prokarin Story

Elaine A. DeLack tells her story of her struggles of trying to bring a treatment option into mainstream medicine. She has been met with great resistance from the NMSS and some pharmaceutical companies. Is the resistance because Prokarinä threatens the cash cow? Read and decide for yourself.